Health Reading List | January 15, 2016 |
Startup Highlight: Cerora
Cerora, like a number of companies, is trying to make the "art" of concussion testing much more of a science. There is obviously a huge sports market that would love to get more insights into concussion protocols beyond the standard today, and Cerora hopes their sensors will help with those insights. See their CEO speak about the product, here.
As always, if you come across news, announcements, videos, or podcasts that you think everyone else would benefit from, e-mail me at scott.munro@startupdigestmail.com or tweet @R_Scott_Munro. | Opportunity Is Knocking  Braintree recently teamed up with Vision Mobile, the world's largest developer survey, to look into untapped opportunities for mobile developers and the Internet of Things. They found that the upside of e-commerce is even bigger than you might think. Read more about the findings here. | | The JP Morgan Healthcare Conference was this week which means lots of new announcements and lots of health enthusiasts in the SF. I swear I've never seen so many suits and ties near Union Square. Check out the overall wrap up above, and highlights from Day 1, Day 2, and Day 3.
Jonathan Bush even saved a life.
| | The biggest news from JPM this week was Illumina announcing its official bid for the liquid biopsy market through Grail. While there are plenty of players in this market already (Foundation, Guardant Health, Caris Life Sciences, etc), it's noteworthy because of their co-investors (Microsoft, Jeff Bezos) and the infrastructure they already have in place. | | I'm a sucker for consulting reports. Here is one on pricing and offering innovation in the med device industry from Deloitte. | | We all know about the move towards consolidation, but as the author notes, "from 2004 to 2011 hospital ownership of physician practices increased from 24% of practices to 49%.3 This consolidation does not appear to have resulted in lower prices, higher quality, or better care experiences." This is a great new look at what consolidation means. The author suggest small practices banding together without giving up the benefits of individual care. I think this is a must read. | | Medication adherence accounts for a huge portion of health care costs in the united states, and for sometime Proteus Health has been working to address this problem. Now a health system has adopted their Proteus Discover technology! | | Many would argue that CRISPR (especially beyond Cas9) is one of the greatest biotech discoveries of this still young century. The invention of the gene editing technique, however, is highly debated. | | You can file this under "Google Betting More on Health Care", while Proteus and others work on medication adherence, Google thinks they can throw their hat in the ring as well. | | | You are receiving this email because you believe that the best startup articles and videos are made by active members of the startup community. Startup Digest, © 2009-2016 by Techstars Central LLC. All rights reserved. Startup Digest is a registered trademark of Techstars Central, LLC. Privacy Policy. | | |
No comments:
Post a Comment